sarepta therapeutics nasdaq

News

FDA Shuts Down Sarepta Gene Therapy Trials

Sarepta to pause Elevidys gene therapy shipments in U.S.

Sarepta Therapeutics (SRPT) said late Monday it will pause all shipments of its Duchenne muscular dystrophy gene therapy, Elevidys, in the U.S.

· 19h

FDA Places Sarepta's Investigational Gene-Therapy Trials on Hold Following Patient Death

MyChesCo on MSN · 14h

FDA Shuts Down Sarepta Gene Therapy Trials After Three Deaths Linked to Liver Failure

Sarepta Therapeutics Stock Is Surging After The Bell: What's Going On?

Sarepta Therapeutics Inc (NASDAQ:SRPT) shares are soaring in Wednesday’s after-hours session after the company announced a ...

5don MSN

Sarepta Therapeutics rises after restructuring, pipeline focus

Sarepta Therapeutics (NASDAQ:SRPT) saw its stock rise in after-hours trading following the announcement of a strategic review ...

Sarepta Therapeutics: What's Happening With SRPT Stock?

The favorable market reaction indicates investor relief at management’s swift measures to rectify the company's worsening ...

Nasdaq1y

Expert Outlook: Sarepta Therapeutics Through The Eyes Of 25 ... - Nasdaq

Ratings for Sarepta Therapeutics (NASDAQ:SRPT) were provided by 25 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.The table below provides a snapshot of ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results